HIV aspartyl protease inhibitors as promising compounds against Candida albicans Andr&eacute; Luis Souza dos Santos

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

468

HTML

5089

Figures (1-3)

429

Sum=5986

Feb 26, 2010 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Biol Chem. Feb 26, 2010; 1(2): 21-30
Published online Feb 26, 2010. doi: 10.4331/wjbc.v1.i2.21

Full Size Figure Download Figure

Figure 2 Aspartyl protease inhibitors used in the current human immunodeficiency virus (HIV) chemotherapy.

Citation: dos Santos ALS. HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos. World J Biol Chem 2010; 1(2): 21-30
URL: https://www.wjgnet.com/1949-8454/full/v1/i2/21.htm
DOI: https://dx.doi.org/10.4331/wjbc.v1.i2.21